Bridgeway Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-159,000
| Closed | -$176K | – | 1448 |
|
|
2022
Q4 | $176K | Sell |
159,000
-5,000
| -3% | -$5.55K | ﹤0.01% | 1114 |
|
|
2022
Q3 | $384K | Buy |
+164,000
| New | +$384K | 0.01% | 964 |
|
|
2020
Q3 | – | Sell |
-31,300
| Closed | -$216K | – | 1375 |
|
|
2020
Q2 | $216K | Sell |
31,300
-294,200
| -90% | -$2.03M | ﹤0.01% | 1135 |
|
|
2020
Q1 | $1.55M | Buy |
325,500
+99,600
| +44% | +$473K | 0.04% | 428 |
|
|
2019
Q4 | $1.97M | Buy |
225,900
+72,300
| +47% | +$631K | 0.03% | 563 |
|
|
2019
Q3 | $511K | Sell |
153,600
-94,300
| -38% | -$314K | 0.01% | 953 |
|
|
2019
Q2 | $1.23M | Buy |
247,900
+20,800
| +9% | +$103K | 0.02% | 669 |
|
|
2019
Q1 | $1.41M | Sell |
227,100
-71,200
| -24% | -$441K | 0.02% | 645 |
|
|
2018
Q4 | $1.01M | Buy |
298,300
+95,000
| +47% | +$320K | 0.01% | 728 |
|
|
2018
Q3 | $1.32M | Buy |
+203,300
| New | +$1.32M | 0.01% | 767 |
|